E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 6
7 / 6Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Case Report

Online Publishing Date:
17 / 05 / 2020

 


Treatment of squamous lung cell carcinoma with inhaled etamsylate

Pedro Cuevas, Sueiro Bendito A, Angulo J, Asin-Cardiel E, Giménez-Gallego G.


Abstract
Aberrant expression of fibroblast growth factor and its receptors plays an important role in carcinogenesis. Here we report that local application of etamsylate, an inhibitor of fibroblast growth factor signaling pathways, led to a clinical improvement in a patient with squamous lung cell carcinoma.

Key words: Squamous lung cell carcinoma, Etamsylate, Fibroblast growth factor


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pedro Cuevas
Articles by Sueiro Bendito A
Articles by Angulo J
Articles by Asin-Cardiel E
Articles by Giménez-Gallego G
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Cuevas P, A SB, J A, E A, G G. Treatment of squamous lung cell carcinoma with inhaled etamsylate. Int J Med Rev Case Rep. 2020; 4(5): 120-121. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma

Web Style

Cuevas P, A SB, J A, E A, G G. Treatment of squamous lung cell carcinoma with inhaled etamsylate. https://www.mdpub.net/?mno=99203 [Access: April 04, 2024]. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma

AMA (American Medical Association) Style

Cuevas P, A SB, J A, E A, G G. Treatment of squamous lung cell carcinoma with inhaled etamsylate. Int J Med Rev Case Rep. 2020; 4(5): 120-121. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma


Vancouver/ICMJE Style

Cuevas P, A SB, J A, E A, G G. Treatment of squamous lung cell carcinoma with inhaled etamsylate. Int J Med Rev Case Rep. (2020), [cited April 04, 2024]; 4(5): 120-121. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma


Harvard Style

Cuevas, P., A, . S. B., J, . A., E, . A. & G, . G. (2020) Treatment of squamous lung cell carcinoma with inhaled etamsylate. Int J Med Rev Case Rep, 4 (5), 120-121. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma


Turabian Style

Cuevas, Pedro, Sueiro Bendito A, Angulo J, Asin-Cardiel E, and Giménez-Gallego G. 2020. Treatment of squamous lung cell carcinoma with inhaled etamsylate. International Journal of Medical Reviews and Case Reports, 4 (5), 120-121. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma


Chicago Style

Cuevas, Pedro, Sueiro Bendito A, Angulo J, Asin-Cardiel E, and Giménez-Gallego G. "Treatment of squamous lung cell carcinoma with inhaled etamsylate." International Journal of Medical Reviews and Case Reports 4 (2020), 120-121. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma


MLA (The Modern Language Association) Style

Cuevas, Pedro, Sueiro Bendito A, Angulo J, Asin-Cardiel E, and Giménez-Gallego G. "Treatment of squamous lung cell carcinoma with inhaled etamsylate." International Journal of Medical Reviews and Case Reports 4.5 (2020), 120-121. Print. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma


APA (American Psychological Association) Style

Cuevas, P., A, . S. B., J, . A., E, . A. & G, . G. (2020) Treatment of squamous lung cell carcinoma with inhaled etamsylate. International Journal of Medical Reviews and Case Reports, 4 (5), 120-121. doi:10.5455/IJMRCR.Treatment-squamous-lung-cell-carcinoma


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500